Growing Acceptance of IP

THE South Pacific nation of Fiji, comprising over 300 islands, has recently signed a Memorandum of Understanding with the Indian Pharmacopoeia Commission for recognising the Indian Pharmacopoeia (IP) as a book of standard.

- 

This MoU will establish a framework for the recognition of the IP as a pharmacopoeia standard for assessing applications for market authorisation for medicinal products manufactured in India. Thus, it will significantly ease regulatory procedures and facilitate greater market access for Indian pharmaceutical products in Fiji. Recognition of IP by more countries will be a huge relief for the exporters as it will help the pharma exporters, including the merchant exporters, to export their products to these countries without retesting. There will be no requirement of applying a separate production method. Like the supply in the domestic market, medicines manufactured in IP can be bought and exported to the IP accepted countries which will treat them like their locally manufactured drugs. But, to the non-accepted countries, a separate method of production has to be followed according to their quality and safety perspective as per each country's pharmacopoei